Syndax Pharmaceuticals, Inc. (SNDX)

NASDAQ

$13.10

$--

(0.00%)

Pre-Market

Syndax Pharmaceuticals, Inc. (SNDX) Live Price Chart

Last updated: ⁦2026-10-20 09:59:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Syndax Pharmaceuticals, Inc. (SNDX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $13.10, with a market capitalization of $1.15B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $12.80 to $25.59. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1.15B
Open	$13.10
Day's High	$29.86
Day's Low	$3.39
Previous Close	$13.09
Volume	470.00
Average Volume	1.70M
P/E Ratio	--
52-Week High	$25.59
52-Week Low	$12.80
Dividend Yield	--
Earnings Date	--

Syndax Pharmaceuticals, Inc. (SNDX) Pre-Market Stock Price

Syndax Pharmaceuticals, Inc. (SNDX) is trading at $13.10 in pre-market trading as of 2026-10-20 09:34:00, up 0.08% ($0.01) from the previous close of $13.09

Pre-market trading shows how investors are pricing SNDX before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.

Syndax Pharmaceuticals, Inc. (SNDX) 7-Day Stock Price Change

Over the past seven days, Syndax Pharmaceuticals, Inc. (SNDX) moved from $16.99 to $13.10, representing a decline of 22.90% ($3.89).

The stock traded between $12.80 and $17.42 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 3.00 million shares, up versus the previous seven-day period, indicating higher trading activity.

SNDX 52-Week Price Position

Position in Range: 2.4%

52W Low$12.80

52W High$25.59

SNDX is currently trading at $13.10, placing it 2.4% of the way from its 52-week low of $12.80 to its 52-week high of $25.59. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Syndax Pharmaceuticals, Inc. (SNDX)?

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Its product candidates include revumenib and axatilimab. It is developing revumenib, a selective menin-MLL inhibitor for KMT2A-rearranged (MLL-r) and NPM1-mutant acute leukemias, including ALL and AML. It is also developing axatilimab, a CSF-1R-blocking antibody for cGVHD and idiopathic pulmonary fibrosis. Entinostat is its oral, small molecule product candidate that has direct effects on both cancer cells and immune regulatory cells. The business activity of the group is functioned through the region of the United States.

Syndax Pharmaceuticals, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	298
Exchange	NASDAQ
Company Website	https://www.syndax.com

How to Buy Syndax Pharmaceuticals, Inc. (SNDX) Stock on MEXC

Eligible investors can buy real shares of Syndax Pharmaceuticals, Inc. (SNDX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for SNDX and Place Your Order

Open the RealStocks trading page and search for SNDX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Syndax Pharmaceuticals, Inc. (SNDX) stock price today?

Syndax Pharmaceuticals, Inc. (SNDX) is currently trading at $ 13.10, up 0.08% ($0.01) from the previous close of $ 13.09. Intraday prices update in real time during regular trading hours.

2.Is SNDX stock going up or down today?

As of 2026-10-20 09:34:00, SNDX is trading at $ 13.10, up 0.08% ($0.01) from its previous close of $ 13.09. The stock has traded between $ 3.39 and $ 29.86 during today’s regular session. Past price movements do not guarantee future results.

3.What is SNDX pre-market price?

As of 2026-10-20 09:34:00, SNDX is trading at $ 13.10 in pre-market trading, up 0.08% ($0.01) from the previous close of $ 13.09. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is SNDX after-hours price?

As of 2026-10-20 09:34:00, SNDX is trading at $ 13.10 in after-hours trading, up 0.08% ($0.01) from the regular-session close of $ 13.09. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is SNDX stock trading now?

SNDX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does SNDX sit relative to its 52-week high and low?

Over the past 52 weeks, SNDX has traded between a low of $ 12.80 and a high of $ 25.59. At $ 13.10, the stock is positioned 2.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Syndax Pharmaceuticals, Inc. in?

Syndax Pharmaceuticals, Inc. (SNDX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Syndax Pharmaceuticals, Inc.'s market capitalization and where is it listed?

Syndax Pharmaceuticals, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 1.15B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is SNDX valued in terms of P/E ratio and EPS?

SNDX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -2.47. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Syndax Pharmaceuticals, Inc. pay a dividend?

Syndax Pharmaceuticals, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.